FDA NDC Directory · JSON-LD · Markdown

FONDAPARINUX SODIUM

NDC 55150-233 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerEugia US LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA206918
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsFONDAPARINUX SODIUM (10 mg/.8mL)
Marketing started20171226
Package count2

External sources

Source: openFDA. Public-domain (CC0).